Redefining Cancer Care: Dr Adeel Khan's Revolution in Myeloma Treatment

Send us FAN MAIL text, include your cell# for a replyMultiple Myeloma Advances: Dr. Adeel Khan on New Treatments, CAR-T, and AI in Research This Episode is available in both audio and video formats on Apple Podcasts and YouTube. Season eight of Villages Vitality Life: Senior Life Unscripted features host Mike Roth interviewing Dr. Adeel Khan, a hematologist-oncologist and epidemiologist at UT Southwestern and director of myeloma epidemiology research and a monoclonal gammopathy precursor clinic. Khan explains multiple myeloma as a plasma cell cancer common in older adults (median onset 69) and notes rising prevalence as patients live longer, with median survival improving from about three years in the 1990s to over nine to ten years today. He outlines treatment evolution from older chemotherapies to targeted drugs and newer immunotherapies, including CAR-T (ide-cel and cilta-cel), citing 2025 ASCO data suggesting some long-term remissions that may be curative. They discuss AI analyzing genomic data, unclear prevention and risk patterns, possible benefits of plant-based diets, early MGUS/GLP-1 data, and how to contact UT Southwestern (214-648-3111).00:00 Season 8 Welcome00:39 Meet Dr Adeel Khan01:46 Why Blood Cancers03:13 What Is Myeloma05:04 Treatment Breakthroughs07:25 Immunotherapy And CAR T10:41 Long Term Remission Stories11:38 Sponsor Health Tip13:19 AI And Genetics Research15:09 Risk Factors And Prevention17:04 Diet And GLP 1 Questions18:56 Clinic Contact Info20:11 Final Thoughts And Sign OffSupport the showVillages Vitality Senior Life Unscripted is Produced & Directed by Mike RothA new episode will be released most Fridays at 9 AMDirect all questions and comments to [email protected] you know a someone who should appear on the show, please contact us at:  [email protected]